Literature DB >> 22847240

Diabetes: normal glucose levels should be the goal.

Lawrence S Phillips, Darin E Olson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22847240     DOI： 10.1038/nrendo.2012.139

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

2.  Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study.

Authors:  Q Gong; E W Gregg; J Wang; Y An; P Zhang; W Yang; H Li; H Li; Y Jiang; Y Shuai; B Zhang; J Zhang; R B Gerzoff; G Roglic; Y Hu; G Li; P H Bennett
Journal:  Diabetologia       Date:  2010-11-03       Impact factor: 10.122

3.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

Authors:  C Weyer; C Bogardus; D M Mott; R E Pratley
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

4.  Basal insulin and cardiovascular and other outcomes in dysglycemia.

Authors:  Hertzel C Gerstein; Jackie Bosch; Gilles R Dagenais; Rafael Díaz; Hyejung Jung; Aldo P Maggioni; Janice Pogue; Jeffrey Probstfield; Ambady Ramachandran; Matthew C Riddle; Lars E Rydén; Salim Yusuf
Journal:  N Engl J Med       Date:  2012-06-11       Impact factor: 91.245

5.  Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.

Authors:  Leigh Perreault; Qing Pan; Kieren J Mather; Karol E Watson; Richard F Hamman; Steven E Kahn
Journal:  Lancet       Date:  2012-06-09       Impact factor: 79.321

6.  Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.

Authors: 
Journal:  Ann Intern Med       Date:  1998-04-01       Impact factor: 25.391

7.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

8.  Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?: U.K. prospective diabetes study 61.

Authors:  Stephen Colagiuri; Carole A Cull; Rury R Holman
Journal:  Diabetes Care       Date:  2002-08       Impact factor: 19.112

9.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

Authors:  Alexandra E Butler; Juliette Janson; Susan Bonner-Weir; Robert Ritzel; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2003-01       Impact factor: 9.461

10.  Glucose challenge test screening for prediabetes and undiagnosed diabetes.

Authors:  L S Phillips; D C Ziemer; P Kolm; W S Weintraub; V Vaccarino; M K Rhee; R Chatterjee; K M V Narayan; D D Koch
Journal:  Diabetologia       Date:  2009-06-26       Impact factor: 10.122
  10 in total
  3 in total

1.  Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS).

Authors:  L Perreault; Q Pan; V R Aroda; E Barrett-Connor; D Dabelea; S Dagogo-Jack; R F Hamman; S E Kahn; K J Mather; W C Knowler
Journal:  Diabet Med       Date:  2017-09-19       Impact factor: 4.359

2.  Glucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists.

Authors:  Esther S Kim; Fumiko Isoda; Irwin Kurland; Charles V Mobbs
Journal:  Endocrinology       Date:  2013-05-24       Impact factor: 4.736

3.  Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.

Authors:  Jennifer L Fiori; Yu-Kyong Shin; Wook Kim; Susan M Krzysik-Walker; Isabel González-Mariscal; Olga D Carlson; Mitesh Sanghvi; Ruin Moaddel; Kathleen Farhang; Shekhar K Gadkaree; Maire E Doyle; Kevin J Pearson; Julie A Mattison; Rafael de Cabo; Josephine M Egan
Journal:  Diabetes       Date:  2013-07-24       Impact factor: 9.461
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.